RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/10556215http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/10556215http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/10556215http://www.w3.org/2000/01/rdf-schema#comment"The NUP98 gene is involved in 3 distinct chromosomal rearrangements, t(7;11)(p15;p15), t(2;11)(q31;p15), and inv(11)(p15q22); all of these NUP98 rearrangements have been identified in the malignant cells of patients with therapy-related acute myelogenous leukemia or myelodysplastic syndrome (t-AML/MDS). Here we report the cloning and characterization of a t(11;20)(p15;q11) translocation from patients with t-MDS. The breakpoint on chromosome 11p15 targets the NUP98 gene and results in the separation of the N-terminal FXFG repeats from the RNA-binding domain located in the C-terminus. The breakpoint on chromosome 20q11 occurs within the gene encoding human DNA topoisomerase I (TOP1). As a result, a chimeric mRNA encoding the NUP98 FXFG repeats fused to the body of DNA topoisomerase I is produced. These results indicate that NUP98 is a recurrent target in therapy-related malignancies, and that TOP1 is a previously unrecognized target for chromosomal translocations."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/author"Aplan P.D."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/author"Aplan P.D."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/author"Felix C.A."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/author"Felix C.A."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/author"Ahuja H.G."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/author"Ahuja H.G."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/date"1999"xsd:gYear
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/date"1999"xsd:gYear
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/pages"3258-3261"xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/pages"3258-3261"xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/title"The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/title"The t(11;20)(p15;q11) chromosomal translocation associated with therapy-related myelodysplastic syndrome results in an NUP98-TOP1 fusion."xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/volume"94"xsd:string
http://purl.uniprot.org/citations/10556215http://purl.uniprot.org/core/volume"94"xsd:string
http://purl.uniprot.org/citations/10556215http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/10556215
http://purl.uniprot.org/citations/10556215http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/10556215
http://purl.uniprot.org/citations/10556215http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/10556215
http://purl.uniprot.org/citations/10556215http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/10556215
http://purl.uniprot.org/uniprot/P11387http://purl.uniprot.org/core/citationhttp://purl.uniprot.org/citations/10556215
http://purl.uniprot.org/uniprot/P52948http://purl.uniprot.org/core/citationhttp://purl.uniprot.org/citations/10556215